Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial

BACKGROUND: The RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial demonstrated that higher-risk patients with atrial fibrillation had lower rates of stroke or systemic embolism and a similar rate of major bleeding, on average, when treated with dabigatran 150mg compared to war...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhardt, Samuel W., Desai, Nihar R., Tang, Yuanyuan, Jones, Philip G., Ader, Jeremy, Spertus, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376053/
https://www.ncbi.nlm.nih.gov/pubmed/34411158
http://dx.doi.org/10.1371/journal.pone.0256338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376053/
https://www.ncbi.nlm.nih.gov/pubmed/34411158
http://dx.doi.org/10.1371/journal.pone.0256338

Ejemplares similares